Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Kabra Drugs Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
524322
INE323K01017
-2.2457859
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
0
3.16
EPS(TTM)
Face Value(
)
Div & Yield %:
0
10
0
Date
Headline
14-Feb-2024
Kabra Drugs reports standalone net loss of Rs 0.11 crore in the December 2023 quarter
06-Feb-2024
Kabra Drugs announces board meeting date
24-Jan-2024
Kabra Drugs to conduct EGM
24-Jan-2024
Kabra Drugs Ltd - Submission Of Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015
24-Jan-2024
Kabra Drugs Ltd - Submission Of Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015
19-Jan-2024
Kabra Drugs to table results
18-Jan-2024
Kabra Drugs Ltd - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday I.E. January 23 2024.
31-Dec-2023
Kabra Drugs Ltd - Closure of Trading Window
09-Dec-2023
Kabra Drugs schedules board meeting
13-Nov-2023
Kabra Drugs reports standalone net loss of Rs 0.13 crore in the September 2023 quarter
1
2